Loading viewer...
investor_presentation
Format: PDF investor_presentation
Halozyme Therapeutics presented its financial update and strategic outlook in January 2024, covering the company's proprietary ENHANZE® drug delivery technology platform, expected revenue growth, and guidance through 2028. The presentation details anticipated commercialization milestones, royalty expectations from partner collaborations, and plans for platform expansion including a high-volume auto-injector development.
conference
20 Pages
investor_presentation
45 Pages
Seabridge Gold
Allscripts Healthcare Solutions Investor Presentation — March 2022
investor_presentationinvestor_presentation
14 Pages
Allscripts Healthcare Solutions
Hyprop Investments Limited Roadshow 2019
investor_presentationinvestor_presentation
33 Pages
Hyprop Investments Limited